Committee On Foreign Investment

According to a report by the New York Post, the recent outbreak of the Zika virus could complicate the $43 billion merger between ChemChina and Syngenta AG (ADR) (NYSE: SYT). The New York Post noted that Syngenta "could be in a position" to create a product to deal with the Zikua...